Skip to content

Drug interactions

Axitinib + Etoposide

Severity: Minor

Axitinib and Etoposide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etoposide is a minor CYP3A4 substrate and not a meaningful CYP3A4 inhibitor, so a clinically relevant rise in axitinib exposure is unlikely. Overlapping myelosuppression or other toxicities are possible but not specific to this pair.

What this interaction means in plain words

Axitinib and Etoposide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Axitinib belongs to Oncology; Etoposide belongs to Oncology.

Evidence level: Low

Why it happens

No well-established mechanism; CYP3A4 inhibition by etoposide is not clinically recognized.

What to do

No dose adjustment is needed. Monitor routine blood counts and tolerability.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Axitinib and Etoposide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Axitinib with Etoposide?

MediHelp rates the interaction as minor. Axitinib and Etoposide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Etoposide is a minor CYP3A4 substrate and not a meaningful CYP3A4 inhibitor, so a clinically relevant rise in axitinib exposure is unlikely. Overlapping myelosuppression or other toxicities are possible but not specific to this pair.

How serious is the interaction between Axitinib and Etoposide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Monitor routine blood counts and tolerability.

What other medicines interact with Etoposide?

MediHelp also lists interactions of Etoposide with, for example, Adenovirus types 4 and 7 live, Pentostatin, Cyclosporin. The full list is on the Etoposide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in